- 2024-08-20 02:13抑制剂SJA710-6|SJA710-6|1397255-09-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:13抑制剂SJA710-6|SJA710-6|1397255-09-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:13抑制剂Sirtuin modulator 1|Sirtuin modulator 1|2070015-26-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:13抑制剂Sirtuin modulator 1|Sirtuin modulator 1|2070015-26-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:13抑制剂Sirtuin modulator 1|Sirtuin modulator 1|2070015-26-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:13抑制剂SIS3 free base|SIS3 free base|1009104-85-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:13抑制剂SIRT2-IN-11|SIRT2-IN-11|1005095-06-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:13抑制剂SIRT2-IN-11|SIRT2-IN-11|1005095-06-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:13抑制剂SIRT2-IN-11|SIRT2-IN-11|1005095-06-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:13抑制剂Simufilam |Simufilam |1224591-33-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:13抑制剂Simufilam |Simufilam |1224591-33-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:13抑制剂Simufilam |Simufilam |1224591-33-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:12抑制剂Sigma-1 receptor antagonist 2|Sigma-1 receptor antagonist 2|1639220-15-7|Adamas life|≥98%（以实测数值为准
- 2024-08-20 02:12抑制剂Sigma-1 receptor antagonist 2|Sigma-1 receptor antagonist 2|1639220-15-7|Adamas life|≥98%（以实测数值为准
- 2024-08-20 02:12抑制剂Sigma-1 receptor antagonist 2|Sigma-1 receptor antagonist 2|1639220-15-7|Adamas life|≥98%（以实测数值为准
- 2024-08-20 02:12抑制剂Shield-1|Shield-1|914805-33-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:12抑制剂Shield-1|Shield-1|914805-33-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:12抑制剂SHIP2-IN-1|SHIP2-IN-1|2252247-80-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:12抑制剂SHIP2-IN-1|SHIP2-IN-1|2252247-80-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:12抑制剂SGN-2FF|SGN-2FF|2089647-47-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
